Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanomaJedd D. Wolchok, Jianda Yuan, Susan E. Krown et al.|Journal of Clinical Oncology|2007Cited by 6
A phase II study of temozolomide (TMZ) and pegylated interferon α-2b (PGI) in the treatment of advanced melanomaSusan E. Krown, Jedd D. Wolchok, Wen-Jen Hwu et al.|Journal of Clinical Oncology|2004Cited by 2
A phase II study of temozolomide (TMZ) and pegylated interferon α-2b (PGI) in the treatment of advanced melanomaSusan E. Krown, Jedd D. Wolchok, P O Livingston et al.|Journal of Clinical Oncology|2004Cited by 0